Reported Standalone quarterly numbers for Suven Life Sciences are:Net Sales at Rs 3.80 crore in June 2023 up 7.29% from Rs. 3.54 crore in June 2022.
Quarterly Net Loss at Rs. 2.87 crore in June 2023 down 24.14% from Rs. 2.31 crore in June 2022.
EBITDA stands negative at Rs. 1.16 crore in June 2023 up 82.5% from Rs. 6.63 crore in June 2022.
| Suven Life Sci shares closed at 62.90 on August 07, 2023 (NSE) and has given 3.88% returns over the last 6 months and -10.27% over the last 12 months. |
| Suven Life Sciences | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'23 | Mar'23 | Jun'22 | | Net Sales/Income from operations | 3.80 | 2.61 | 3.54 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 3.80 | 2.61 | 3.54 | | EXPENDITURE | | Consumption of Raw Materials | -- | -- | -- | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -- | -- | -- | | Power & Fuel | -- | -- | -- | | Employees Cost | 4.54 | 3.18 | 4.16 | | Depreciation | 1.66 | 1.67 | 1.58 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | 4.38 | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 6.05 | 1.17 | 6.45 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -8.46 | -7.80 | -8.65 | | Other Income | 5.64 | 5.60 | 0.44 | | P/L Before Int., Excpt. Items & Tax | -2.82 | -2.20 | -8.21 | | Interest | 0.05 | 0.05 | 0.10 | | P/L Before Exceptional Items & Tax | -2.87 | -2.25 | -8.31 | | Exceptional Items | -- | -- | 6.00 | | P/L Before Tax | -2.87 | -2.25 | -2.31 | | Tax | -- | -- | -- | | P/L After Tax from Ordinary Activities | -2.87 | -2.25 | -2.31 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -2.87 | -2.25 | -2.31 | | Equity Share Capital | 21.81 | 21.81 | 14.54 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.13 | -0.05 | -0.16 | | Diluted EPS | -0.13 | -0.05 | -0.16 | | EPS After Extra Ordinary | | Basic EPS | -0.13 | -0.05 | -0.16 | | Diluted EPS | -0.13 | -0.05 | -0.16 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
